Hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer

BACKGROUND: To investigate the clinical outcomes and toxicity of hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer (NSCLC). METHODS: Patients treated with radiotherapy at a dose of 4–6 Gy per fraction using fixed‐field intensity modulated radiotherapy (IMRT) o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Thorac Cancer
Asıl Yazarlar: Jiang, Wei, Wang, Jian‐Yang, Wang, Jing‐Bo, Liang, Jun, Hui, Zhou‐Guang, Wang, Xiao‐Zhen, Zhou, Zong‐Mei, Wang, Lu‐Hua
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2015
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4846617/
https://ncbi.nlm.nih.gov/pubmed/27148414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12327
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller